Calithera Biosciences Inc. (CALA) Shares Active after Upgrade at Zacks Investment Research

Calithera Biosciences Inc. (NASDAQ: CALA) shares slid back in value Monday Nov 14 with lighter trade volume than normal after a number of analysts weighed in on the investing value of the stock with a upgraded rating.

Meanwhile as investors continued to try and decipher policy proposals of President-elect Donald Trump’s administration, the Dow Jones Industrial Average DJIA, +0.11% rose 21.03 points, or 0.1%, to finish at 18,868.69, its third straight record close.
The blue-chip index had also touched a historic high of 18,934.05 during the session.

The S&P 500 index SPX, -0.01% fell 0.25 points to end at 2,164.20, and the Nasdaq Composite COMP, -0.36% dropped 18.72 points, or 0.4%, to close at 5,218.40.

Analysts at Zacks Investment Research upgraded shares of Calithera Biosciences Inc. (NASDAQ: CALA) from Hold to Buy today. With a rating of Buy on the shares, Calithera Biosciences Inc. has a 52-week high of $8.85. The one-year price target of $0.00 is less than the opening price of $3.30, that has caused a fair amount of other analysts to report on the stock recently. Stock prices sometimes get a boost to the upside when analysts upgrade a stock.

Calithera Biosciences Inc. (NASDAQ: CALA) shares last traded at $3.15, which is a dip of $0.15 per share or -4.55% from the previous closing price. Opening at $3.30, they fluctuated from $3.15 and $3.40 throughout the day.

Calithera Biosciences Inc. (NASDAQ: CALA) currently has a market cap of 61.39M.

Calithera Biosciences Inc. (NASDAQ: CALA) Average Daily Trading Volume

The stock’s average daily volume is 176,031 shares out of a total float 9,729,000 and some 174,027 shares traded hands yesterday, below the average. Trading volume is likely to increase in the next few days as swing traders often use swings in trading volume to pinpoint large volume growth or circulation by institutional investors.

While increased trading for one day will not mean much, however, a trend of heavy trading volume on the buy side over a series of days or weeks sends a positive signal to market traders that institutions may be moving in, so institutional sponsorship is very important.

Institutional sponsorship is defined by ownership of a stock by mutual funds, banks, pension funds and other large institutions.

These professional investors have teams of analysts that investigate thousands of stocks. So watching their interests is a good way to ensure you are buying the right stocks.

Calithera Biosciences Inc. (NASDAQ: CALA) Moving Averages

A moving average can also act as support or resistance. In an uptrend a 50-day, 100-day or 200-day moving average may act as a support level, as shown in the figure below.

This is because the average acts like a floor (support), so the price bounces up off of it.

In a downtrend a moving average may act as resistance; like a ceiling, the price hits it and then starts to drop again.

By identifying trends, moving averages allow traders to make those trends work in their favor and increase the number of successful trades.

Trades for Calithera Biosciences Inc. (NASDAQ: CALA) have ranged from $2.20 – 8.85, and the stock now has a 50-day MA of $2.93 and 200-day MA of $3.65. Today’s last price is 64.41%% lower than the 52 week high of $8.85.

Earnings growth is a critical factor to consider when investing in stocks and investors identify companies that have increased their earnings by at least 25% for a 3 year period.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of the website. Readers should not consider statements made by the author as formal recommendations and should consult their financial adviser before making any investment decisions. To read our full disclosure, please see our terms and conditions page.

Leave a Reply

Your email address will not be published. Required fields are marked *